Enterprise Value
-8.916M
Cash
25.83M
Avg Qtr Burn
-14.83M
Short % of Float
0.86%
Insider Ownership
15.39%
Institutional Own.
23.26%
Qtr Updated
09/30/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Vazalore (325mg and 81mg) Details Pain reliever / fever reducer; aspirin therapy for vascular indications | Approved Quarterly sales |